Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 15

1.

Combined liver cell and bile duct carcinoma.

ALLEN RA, LISA JR.

Am J Pathol. 1949 Jul;25(4):647-55. No abstract available.

2.

Hepatitis B virus and intrahepatic cholangiocarcinoma.

Gatselis NK, Tepetes K, Loukopoulos A, Vasiou K, Zafiriou A, Gioti C, Dalekos GN.

Cancer Invest. 2007 Feb;25(1):55-8.

PMID:
17364558
3.

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.

Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM.

Am J Gastroenterol. 2007 May;102(5):1016-21. Epub 2007 Feb 23.

PMID:
17324130
4.

Hepatic progenitor cells in human liver tumor development.

Libbrecht L.

World J Gastroenterol. 2006 Oct 21;12(39):6261-5. Review.

5.

Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.

Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M.

Hum Pathol. 2006 Sep;37(9):1211-6. Epub 2006 Jul 18.

PMID:
16938527
6.

Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.

Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.

J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98.

PMID:
16843869
7.

Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.

Hai S, Kubo S, Yamamoto S, Uenishi T, Tanaka H, Shuto T, Takemura S, Yamazaki O, Hirohashi K.

Dig Surg. 2005;22(6):432-9. Epub 2006 Feb 10.

PMID:
16479112
8.

High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.

Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K.

J Clin Microbiol. 2003 Dec;41(12):5449-55.

9.

Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.

Tickoo SK, Zee SY, Obiekwe S, Xiao H, Koea J, Robiou C, Blumgart LH, Jarnagin W, Ladanyi M, Klimstra DS.

Am J Surg Pathol. 2002 Aug;26(8):989-97.

PMID:
12170085
10.

Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.

Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D.

Cancer. 2002 Apr 1;94(7):2040-6.

11.

Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.

Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ.

Hepatology. 2001 Jan;33(1):277-86.

PMID:
11124846
12.

Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.

Ng IO, Shek TW, Nicholls J, Ma LT.

J Gastroenterol Hepatol. 1998 Jan;13(1):34-40.

PMID:
9737569
13.
14.

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.

Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L.

Cancer. 1985 Jan 1;55(1):124-35.

15.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk